Clinical trial
A Feasibility Study of Multispectral Optoacoustic Tomography (MSOT) Imaging in Patients With Tumors
NCT05488483 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Feasibility Study of Multispectral Optoacoustic Tomography (MSOT) Imaging in Patients With Tumors
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 27, 2022
- Completion date
- July 27, 2026
- Enrollment
- 12 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, melanoma